Literature DB >> 28642025

Total Laparoscopic Resection Surgery for a Cervical Carcinoma that Recurred in the Pelvic Sidewall After Radical Hysterectomy and Adjuvant Concurrent Chemoradiotherapy.

Hiroyuki Kanao1, Yoichi Aoki2, Kazuyoshi Kato2, Maki Matoda2, Sanshiro Okamoto2, Hidetaka Nomura2, Kohei Omatsu2, Kuniko Utsugi2, Nobuhiro Takeshima2.   

Abstract

STUDY
OBJECTIVE: To show total laparoscopic resection of a cervical carcinoma that recurred at the left pelvic sidewall after radical hysterectomy and concurrent chemoradiotherapy (CCRT).
DESIGN: A step-by-step demonstration of the technique in a surgical video, including the strategy for achieving complete surgical resection with negative margins (R0 resection) (Canadian Task Force Classification III).
SETTING: For high-risk cervical carcinoma, radical hysterectomy and adjuvant CCRT is the standard treatment, but even this multimodal therapy cannot prevent recurrence. When the recurrent mass is localized in the pelvic cavity, R0 resection offers the most promise; however, for laterally recurring cervical carcinoma, the resectability rate is low, owing mainly to severe adhesion and fibrosis, and thus the morbidity and mortality rates are high. Because laparoscopy optimizes visualization and provides for meticulous dissection, laparoscopic surgery can be advantageous over open surgery for resection of cervical carcinoma recurring at the pelvic sidewall after radical hysterectomy and adjuvant CCRT.
INTERVENTIONS: A 48-year-old woman with stage IB2 cervical adenocarcinoma had undergone radical hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and, because lymph node metastasis was found in the removed lymph nodes, adjuvant CCRT. At 6 months after completion of this multimodal therapy, a recurrent mass was detected at the left pelvic sidewall. The mass involved the left ureter, bladder, left internal iliac vessels, and endopelvic fascia, and left renal function was unrecoverable. Tumor excision and left nephroureterectomy were performed laparoscopically. The total operating time was 608 minutes, blood loss volume was 250 mL, and blood transfusion was not required. Complete tumor clearance (R0 resection) was achieved by resection of the left internal iliac vessels, left internal obturator muscle, left pubococcygeal muscle, left ureter, and bladder. There were no postoperative complications. Institutional Review Board approval was obtained through our local Ethics Committee in Cancer Institute hospital.
CONCLUSION: Complete laparoscopic resection surgery for recurrent cervical carcinoma at the pelvic sidewall after radical hysterectomy and adjuvant CCRT is technically feasible. The good visualization and meticulous dissection provided during laparoscopic surgery make the approach advantageous for the management of laterally recurrent cervical carcinoma.
Copyright © 2017 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pelvic sidewall; Recurrent cervical carcinoma; Total laparoscopic resection

Mesh:

Year:  2017        PMID: 28642025     DOI: 10.1016/j.jmig.2017.04.014

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  2 in total

1.  High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.

Authors:  Mio Nakata; Ken Yoshida; Taiju Shimbo; Nobuhiko Yoshikawa; Hiroto Yoshioka; Akihiro Hori; Chikara Sato; Yasuo Uesugi; Yuhei Kogata; Koji Masui; Naoya Murakami; Tairo Kashihara; Hironori Akiyama; Nikolaos Tselis; Masahide Ohmichi; Keiji Nihei
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

2.  Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer.

Authors:  Ryo Ohno; Yoshiko Matsumoto; Hideki Nagano; Akira Komono; Naoya Aisu; Gumpei Yoshimatsu; Suguru Hasegawa
Journal:  J Gynecol Oncol       Date:  2021-11-30       Impact factor: 4.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.